Get 20% lifetime commission for referring investors to digrin.com
here.
Entrada Therapeutics, Inc. ( TRDA) - Key Metrics
TRDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | -$1.01 | -$0.85 | -$0.85 |
| 2026Q1 | $0.02 | -$0.95 | -$1 | -$1 |
| 2025Q4 | $0.03 | -$0.95 | -$0.78 | -$0.77 |
| 2025Q3 | $0.04 | -$1.06 | -$0.68 | -$0.68 |
| 2025Q2 | $0.05 | -$1.04 | -$0.71 | -$0.72 |
TRDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.82 |
| 2026Q1 | 0% | -3.32 |
| 2025Q4 | 0% | -2.71 |
| 2025Q3 | 0% | -1.37 |
| 2025Q2 | 0% | -1.62 |
TRDA
Price: $4.37
52 week price:
Earnings Per Share: -4.01 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 22900
Market Capitalization: 201.9 million